Psilocybin vs. SSRIs
A fascinating exploration reveals that while participants had higher expectations for psilocybin therapy compared to SSRIs, pretrial expectancy only predicted responses to SSRIs. This challenges the notion that psychedelic therapy is merely a placebo effect, suggesting that there may be deeper therapeutic mechanisms at play. The conversation hints at the potential of psilocybin to enhance global connectivity, leaving listeners intrigued about the unexplored dimensions of its efficacy.In this clip
From this podcast
Huberman Lab
Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health | Huberman Lab Podcast
Related Questions
What are the details of the psilocybin vs Lexapro study that Andrew Huberman discusses?
What are the details of the psilocybin vs Lexapro study that Andrew Huberman discusses in the episode Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health | Huberman Lab Podcast and the clip Psychedelics Research Insights?
What are the therapeutic outcomes linked to psilocybin?